IL6 and exanthem: Some potential biomarkers of toxicity during TKI therapy include circulating cytokines, such as IL-6 and TNF-alpha, which have been associated with inflammatory side effects like skin rashes, gastrointestinal disturbances, and fatigue (27, 28).